Literature DB >> 25409896

Crohn's disease.

Rahul Kalla1, Nicholas T Ventham1, Jack Satsangi1, Ian D R Arnott2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25409896     DOI： 10.1136/bmj.g6670

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  27 in total

Review 1.  Prognostic factors affecting outcomes in fistulating perianal Crohn's disease: a systematic review.

Authors:  G C Braithwaite; M J Lee; D Hind; S R Brown
Journal:  Tech Coloproctol       Date:  2017-06-20       Impact factor: 3.781

Review 2.  Pharmacogenetic biomarkers of response in Crohn's disease.

Authors:  T M Linares-Pineda; M Cañadas-Garre; A Sánchez-Pozo; M Á Calleja-Hernández
Journal:  Pharmacogenomics J       Date:  2017-06-20       Impact factor: 3.550

3.  Sex-Specific Issues in Inflammatory Bowel Disease.

Authors:  Elizabeth Rosenblatt; Sunanda Kane
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-09

Review 4.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors:  Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

Review 5.  Skin Manifestations of Inflammatory Bowel Disease.

Authors:  Thomas Greuter; Alexander Navarini; Stephan R Vavricka
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 6.  Approach to the Patient with Mild Crohn's Disease: a 2016 Update.

Authors:  Frank I Scott; Gary R Lichtenstein
Journal:  Curr Gastroenterol Rep       Date:  2016-09

7.  Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn's Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany.

Authors:  Niels Teich; Michael Bläker; Frank Holtkamp-Endemann; Eric Jörgensen; Andreas Stallmach; Susanne Hohenberger
Journal:  Inflamm Intest Dis       Date:  2020-12-18

8.  Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn's disease.

Authors:  Li Ma; Wenbo Li; Nan Zhuang; Hong Yang; Wei Liu; Weixun Zhou; Yuxin Jiang; Jianchu Li; Qingli Zhu; Jiaming Qian
Journal:  Therap Adv Gastroenterol       Date:  2021-06-09       Impact factor: 4.409

Review 9.  Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.

Authors:  Sun Young Moon; Kwang Dong Kim; Jiyun Yoo; Jeong-Hyung Lee; Cheol Hwangbo
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

10.  Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.

Authors:  Rahul Kalla; Nicholas A Kennedy; Nicholas T Ventham; Ray K Boyapati; Alex T Adams; Elaine R Nimmo; Micaela R Visconti; Hazel Drummond; Gwo-Tzer Ho; Rebecca J Pattenden; David C Wilson; Jack Satsangi
Journal:  Am J Gastroenterol       Date:  2016-09-06       Impact factor: 12.045
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.